EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

Clinical trial NCT04998604 · COMPLETED

Trial details

NCT number: NCT04998604
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Rhinosinusitis With Nasal Polyps Asthma

Start date: 2021-09-27
Primary completion: 2024-10-16
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.